Effect of SARS-CoV-2 Vaccination on Symptoms from Post-Acute Sequelae of COVID-19: Results from the Nationwide VAXILONG Study.

Marc ScherlingerLuc PijnenburgEmmanuel ChatelusLaurent ArnaudJacques-Eric GottenbergJean SibiliaRenaud Felten

Published in: Vaccines (2021)

Our study suggests that SARS-CoV-2 vaccination is well tolerated in the majority of PASC patients and has good immunogenicity. Disseminating these reassuring data might prove crucial to increasing vaccine coverage in patients with PASC.

Keyphrases

sars cov
end stage renal disease
respiratory syndrome coronavirus
ejection fraction
chronic kidney disease
electronic health record
peritoneal dialysis
depressive symptoms
machine learning
big data
artificial intelligence
patient reported